Objective To provide an update on key safety metrics after transfusion of convalescent plasma
in hospitalized coronavirus 2019 (COVID-19) patients, having previously demonstrated …

Background Convalescent plasma has been widely used to treat coronavirus disease 2019 (Covid-19)
under the presumption that such plasma contains potentially therapeutic …

Importance Passive antibody transfer is a longstanding treatment strategy for infectious
diseases that involve the respiratory system. In this context, human convalescent plasma has …

Background The United States (US) Expanded Access Program (EAP) to coronavirus disease
2019 (COVID-19) convalescent plasma was initiated in response to the rapid spread of …

Successful therapeutics and vaccines for coronavirus disease 2019 (COVID-19) have
harnessed the immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-…

Objective To examine the association of COVID-19 convalescent plasma transfusion with
mortality and the differences between subgroups in hospitalized patients with COVID-19. …

In manual-cued speech (MCS) a speaker produces hand gestures to resolve ambiguities
among speech elements that are often confused by speechreaders. The shape of the hand …

Convalescent plasma is used to treat COVID-19. There are theoretical concerns about the
impact of pro-coagulant factors in convalescent plasma on the coagulation cascade …

Background The United States (US) Expanded Access Program (EAP) to COVID-19
convalescent plasma was initiated in response to the rapid spread of severe acute respiratory …

Management of infections in the immunocompromised patient requires unique considerations
that are not typically seen in the immunocompetent. Immunocompromised hosts require a …